Latest kidney transplant Stories
Data presented at the American Transplant Congress HORSHOLM, Denmark, May 4, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that once-daily Envarsus(®) XR (tacrolimus
Six-way Kidney "Swap" involves 12 patients, five surgeons over two days SAN FRANCISCO, March 5, 2015 /PRNewswire/ -- Twelve patients today are preparing to participate in a rare, two-day,
HORSHOLM, Denmark, March 3, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) ('Veloxis') today published the annual report of Veloxis Pharmaceuticals A/S for the financial year 2014.
- Study published in American Journal of Transplantation - HORSHOLM, Denmark, Nov.
Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation.
Making it easier for patients to receive care close to home: Saint Luke's Kidney Transplant Satellite Clinic in Wichita will open in August 2014 to serve patients in the Wichita region who
- Result seen across stable and de novo kidney transplant patients - HORSHOLM, Denmark, June 30, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that once-daily
WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- Today RPA joins 14 other kidney organizations to promote changes in kidney care on Capitol Hill.
Dr. Rubin to Lead Saint Luke's Kidney Transplant Program Kansas City, MO (PRWEB) April 02, 2014 Mario F.
Biopsy-detected injury in donated kidneys was modestly associated with a delay in organ function in the first week after transplantation, but only for donor kidneys already known to be at high risk.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).